MAPS Bulletin Spring 2018: Vol 28, No. 1 Special Edition: Breakthrough

Download this entire issue or browse individual articles by title below.

Front Cover
Breakthrough | Spring 2018
Back Cover
Therapy Training Quilt

 

Front Cover
1 Developing MDMA into a Prescription Medicine for PTSD MAPS
Table of Contents MAPS
2 From the Desk of Rick Doblin, Ph.D., MAPS Founder and Executive Director Rick Doblin, Ph.D.
4 Research News MAPS
10 MAPS in the Media MAPS
12 Breakthrough Therapy Designation: Streamlining the Path to Approval Matthew J. Neal
15 How to Change Your Mind: An interview with author Michael Pollan
Brad Burge
18 MAPS-Sponsored Research at the 2017 Annual Meeting of the International Society for Traumatic Stress Studies: Signs of Breaking Through Resistance Michael Mithoefer, M.D.
22 From Print to Presentations: The Importance of Communicating Findings from Psychedelic and Cannabis Studies Ilsa Jerome, Ph.D., & Allison Feduccia, Ph.D.
25 Clinical Supervision in MDMA Therapy Training: An Ethical Commitment Shannon Clare Carlin, M.A.
27 The Right to Science and Freedom of Research with Scheduled Substances: MAPS at the United Nations 61st Commission on Narcotic Drugs Natalie Lyla Ginsberg, M.S.W.
30 From the Personal to the Political: Why Psychedelic Therapy is a Bipartisan Issue SGT(R) Jonathan M Lubecky
32 I Tried MDMA-Assisted Psychotherapy, and I Still Have PTSD: Here’s What I Think About It Kristina Cizmar Eklund
35 Cryptocurrency Philanthropy Catapults Fundraising for Phase 3 Trials MAPS
39 The Zendo Project: Evolving Psychedelic Support Since 2012 Ryan Beauregard
42 Psychedelic Integration Through Community Service: My Experience Starting a Psychedelic Society Kwasi Adusei
44 The Beckley Foundation Brings Microdosing Under the Microscope Amanda Feilding
47 Black Masks, Rainbow Bodies: Psychedelics and Race Nicholas Powers
52 Breaking on Through: The Psychedelic Experience 50 Years Later John Densmore of The Doors
Back Cover